7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
NCT07175077 is an observational study sponsored by University of Missouri-Columbia. As of 21 Nov 2026, it is recruiting participants. It studies Brain Metastases and Small-cell Lung Cancer. The registry lists an enrollment of 20 participants at 1 site in 1 country. The registry lists a start date of 1 Nov 2025 and a primary completion date of 30 Sept 2027.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT07175077 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | University of Missouri-Columbia |
| Enrollment | 20 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Brain Metastases and Small-cell Lung Cancer |
| Start | 1 Nov 2025 |
| Primary completion | 30 Sept 2027 |
| Study completion | 30 Sept 2027 |
| Last update posted | 2 Dec 2025 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Bo Lu, MD
CHAIR & PROFESSOR, DEPARTMENT OF RADIATION ONCOLOGY
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Missouri
Columbia
Bo Lu, MDRecruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT07175077
Each answer restates registry values shown on this page.
What is NCT07175077?
NCT07175077 is an observational study sponsored by University of Missouri-Columbia. It studies Brain Metastases and Small-cell Lung Cancer.
Is NCT07175077 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT07175077?
The registry names Bo Lu, MD (principal investigator, CHAIR & PROFESSOR, DEPARTMENT OF RADIATION ONCOLOGY) as the overall official.
Where does NCT07175077 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT07175077 expected to complete?
The registry lists a primary completion date of 30 Sept 2027 and a study completion date of 30 Sept 2027. The sponsor last updated the record on 2 Dec 2025.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.